Stephen R Durham Selected Research

Allergic Rhinitis

12/2022	Local nasal immunotherapy for allergic rhinitis: A systematic review and meta-analysis.
7/2022	Long-term efficacy of the sublingual and subcutaneous routes in allergen immunotherapy.
1/2022	Allergen immunotherapy for long-term tolerance and prevention.
12/2021	Technical standards in allergen exposure chambers worldwide - an EAACI Task Force Report.
1/2021	Repetitive nasal allergen challenge in allergic rhinitis: Priming and Th2-type inflammation but no evidence of remodelling.
1/2021	Passive Prophylactic Administration with a Single Dose of Anti-Fel d 1 Monoclonal Antibodies REGN1908-1909 in Cat Allergen-induced Allergic Rhinitis: A Randomized, Double-Blind, Placebo-controlled Clinical Trial.
1/2020	Toll-Like Receptor Agonists as Adjuvants for Allergen Immunotherapy.
1/2018	Synchronous immune alterations mirror clinical response during allergen immunotherapy.
12/2017	Mechanisms of allergen immunotherapy for inhaled allergens and predictive biomarkers.
6/2017	Intradermal grass pollen immunotherapy increases TH2 and IgE responses and worsens respiratory allergic symptoms.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stephen R Durham Research Topics

Disease

36	Allergic Rhinitis 12/2022 - 05/2002
29	Asthma (Bronchial Asthma) 07/2022 - 05/2002
29	Hypersensitivity (Allergy) 07/2022 - 03/2002
22	Seasonal Allergic Rhinitis (Hay Fever) 01/2021 - 01/2002
14	Inflammation (Inflammations) 12/2021 - 12/2003
12	Rhinitis 01/2022 - 12/2003
9	Anaphylaxis (Anaphylactic Shock) 01/2021 - 03/2002
3	Peanut Hypersensitivity (Peanut Allergy) 01/2021 - 05/2015
3	Eosinophilia 01/2021 - 01/2016
3	Bites and Stings (Sting) 01/2019 - 03/2004
2	Respiratory Tract Diseases (Respiratory Tract Disease) 12/2021 - 01/2011
2	Rhinosinusitis 01/2019 - 01/2016
2	Nasal Polyps (Nasal Polyp) 01/2019 - 10/2017
2	Autoimmune Diseases (Autoimmune Disease) 12/2008 - 11/2004
1	Food Hypersensitivity (Food Allergy) 01/2021
1	Sleep Deprivation 12/2019
1	Perennial Allergic Rhinitis 10/2016
1	Virus Diseases (Viral Diseases) 01/2016
1	Polyps 01/2016
1	Airway Remodeling 12/2015
1	Hepatitis B 04/2013
1	Hepatitis 04/2013
1	Wounds and Injuries (Trauma) 02/2013
1	Pneumonia (Pneumonitis) 02/2013
1	Disease Progression 10/2012
1	Psoriasis (Pustulosis Palmaris et Plantaris) 12/2009
1	Fibrosis (Cirrhosis) 12/2009
1	Cough 11/2009
1	Chronic Cough 11/2009
1	Occupational Asthma 03/2006

Drug/Important Bio-Agent (IBA)

40	AllergensIBA 01/2022 - 01/2002
28	Immunoglobulin E (IgE)IBA 12/2021 - 01/2002
8	TabletsIBA 12/2019 - 04/2006
6	AntibodiesIBA 12/2021 - 04/2003
5	Immunoglobulin G (IgG)IBA 12/2021 - 05/2011
5	CytokinesIBA 01/2021 - 01/2002
5	Peptides (Polypeptides)IBA 01/2019 - 04/2013
4	Arthropod VenomsIBA 07/2022 - 01/2019
4	EpitopesIBA 12/2021 - 04/2013
4	Immunoglobulin A (IgA)IBA 12/2021 - 01/2004
4	AntigensIBA 01/2019 - 11/2004
3	Interleukin-5 (Interleukin 5)IBA 01/2021 - 01/2016
3	Pharmaceutical PreparationsIBA 01/2019 - 03/2002
3	Messenger RNA (mRNA)IBA 01/2018 - 04/2005
3	GrazaxIBA 01/2015 - 01/2010
3	VaccinesIBA 03/2014 - 05/2008
3	Interleukin-10 (Interleukin 10)IBA 12/2008 - 03/2004
2	Interleukin-13IBA 01/2021 - 01/2016
2	Biomarkers (Surrogate Marker)IBA 12/2019 - 01/2016
2	Histamine (Histamine Dihydrochloride)FDA Link 06/2017 - 08/2013
2	Omalizumab (Xolair)FDA Link 12/2016 - 09/2007
2	Anti-Allergic Agents (Antiallergic Agents)IBA 02/2016 - 05/2011
2	anti-IgE antibodiesIBA 01/2016 - 09/2007
2	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 04/2014 - 03/2014
2	Proteins (Proteins, Gene)FDA Link 01/2014 - 12/2009
2	ChemokinesIBA 12/2009 - 12/2003
2	levocetirizine FDA LinkGeneric 10/2006 - 10/2004
1	Interleukin-4 (Interleukin 4)IBA 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	Epinephrine (Adrenaline)FDA LinkGeneric 01/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020
1	Histamine Antagonists (Antihistamines)IBA 01/2020
1	CI 22IBA 12/2019
1	OvalbuminIBA 01/2018
1	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 01/2018
1	Annexin A5IBA 01/2018
1	Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA 12/2017
1	mepolizumabIBA 10/2017
1	Interleukin-33IBA 01/2016
1	CollagenIBA 12/2015
1	Extracellular Matrix ProteinsIBA 12/2015
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 12/2015
1	Silk FDA Link 11/2014
1	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 09/2014
1	HLA-DR1 Antigen (HLA DR1 Antigen)IBA 04/2014
1	Wasp Venoms (Venom, Wasp)IBA 01/2014
1	Membrane Proteins (Integral Membrane Proteins)IBA 04/2013
1	Recombinant Fusion ProteinsIBA 04/2013
1	Interleukin-22 (IL-22)IBA 02/2013
1	Eosinophil Cationic ProteinIBA 06/2012
1	Tryptases (Tryptase)IBA 06/2012
1	Capsaicin (Zostrix)FDA Link 11/2009
1	Transforming Growth Factor beta (TGF-beta)IBA 12/2008
1	Cholecalciferol (Vitamin D3)FDA Link 12/2008
1	SteroidsIBA 12/2008
1	aluminum sulfate (alum)IBA 05/2008
1	Cytidine DeaminaseIBA 01/2007
1	Immunoglobulin epsilon-ChainsIBA 01/2007
1	SuperantigensIBA 08/2005
1	Interleukin-9 (Interleukin 9)IBA 07/2005
1	CytidineIBA 04/2005
1	monophosphoryl lipid AIBA 12/2004

Therapy/Procedure

44	Immunotherapy 12/2022 - 01/2002
10	Therapeutics 12/2019 - 05/2002
4	Drug Therapy (Chemotherapy) 11/2019 - 02/2006
3	Injections 06/2017 - 05/2008
2	Aftercare (After-Treatment) 02/2011 - 01/2010
1	Biological Therapy 01/2016
1	Intradermal Injections 08/2013
1	Duration of Therapy 01/2011